Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Third-generation anti-CD19 chimeric antigen receptor T-cells incorporating a TLR2 domain for relapsed or refractory B-cell lymphoma: a phase I clinical trial protocol (ENABLE).

George P, Dasyam N, Giunti G, Mester B, Bauer E, Andrews B, Perera T, Ostapowicz T, Frampton C, Li P, Ritchie D, Bollard CM, Hermans IF, Weinkove R.

BMJ Open. 2020 Feb 9;10(2):e034629. doi: 10.1136/bmjopen-2019-034629.

2.

Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial.

Stanworth SJ, Killick S, McQuilten ZK, Karakantza M, Weinkove R, Smethurst H, Pankhurst LA, Hodge RL, Hopkins V, Thomas HL, Deary AJ, Callum J, Lin Y, Wood EM, Buckstein R, Bowen D; REDDS Investigators.

Br J Haematol. 2020 Jan 20. doi: 10.1111/bjh.16347. [Epub ahead of print]

PMID:
31960409
3.

Correction to: A novel generation 1928zT2 CAR T cells induce remission in extramedullary relapse of acute lymphoblastic leukemia.

Weng J, Lai P, Qin L, Lai Y, Jiang Z, Luo C, Huang X, Wu S, Shao D, Deng C, Huang L, Lu Z, Zhou M, Zeng L, Chen D, Wang Y, Chen X, Geng S, Weinkove R, Tang Z, He C, Li P, Du X.

J Hematol Oncol. 2019 Nov 20;12(1):117. doi: 10.1186/s13045-019-0816-4.

4.

Maintaining a fit T-cell compartment: lymphoma treatment sequencing in the era of chimeric antigen receptor T-cell therapies.

Dickinson M, Weinkove R.

Intern Med J. 2019 Oct;49(10):1338. doi: 10.1111/imj.14453. No abstract available.

PMID:
31602776
5.

Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions.

Fischer K, Al-Sawaf O, Bahlo J, Fink AM, Tandon M, Dixon M, Robrecht S, Warburton S, Humphrey K, Samoylova O, Liberati AM, Pinilla-Ibarz J, Opat S, Sivcheva L, Le Dû K, Fogliatto LM, Niemann CU, Weinkove R, Robinson S, Kipps TJ, Boettcher S, Tausch E, Humerickhouse R, Eichhorst B, Wendtner CM, Langerak AW, Kreuzer KA, Ritgen M, Goede V, Stilgenbauer S, Mobasher M, Hallek M.

N Engl J Med. 2019 Jun 6;380(23):2225-2236. doi: 10.1056/NEJMoa1815281. Epub 2019 Jun 4.

PMID:
31166681
6.

Selecting costimulatory domains for chimeric antigen receptors: functional and clinical considerations.

Weinkove R, George P, Dasyam N, McLellan AD.

Clin Transl Immunology. 2019 May 11;8(5):e1049. doi: 10.1002/cti2.1049. eCollection 2019. Review.

7.

A randomized controlled feasibility trial of paracetamol during febrile neutropenia in hemato-oncology patients.

Weinkove R, Bowden E, Wood C, Campion V, Carter J, Hall R, Weatherall M, Beasley R, Young P.

Leuk Lymphoma. 2019 Jun;60(6):1540-1547. doi: 10.1080/10428194.2018.1538512. Epub 2019 Jan 18.

PMID:
30656993
8.

Enhancing T cell responses and tumour immunity by vaccination with peptides conjugated to a weak NKT cell agonist.

Compton BJ, Farrand KJ, Tang CW, Osmond TL, Speir M, Authier-Hall A, Wang J, Ferguson PM, Chan STS, Anderson RJ, Cooney TR, Hayman CM, Williams GM, Brimble MA, Brooks CR, Yong LK, Metelitsa LS, Zajonc DM, Godfrey DI, Gasser O, Weinkove R, Painter GF, Hermans IF.

Org Biomol Chem. 2019 Jan 31;17(5):1225-1237. doi: 10.1039/c8ob02982b.

PMID:
30656346
9.

Flow Cytometric Analysis of Mechanically Disaggregated Bone Marrow Trephine Biopsies.

Wheeler M, White G, Brockie S, Dickson M, Weinkove R.

Cytometry B Clin Cytom. 2018 Nov;94(6):935-940. doi: 10.1002/cyto.b.21646. Epub 2018 Oct 22. Review.

10.

Managing hypogammaglobulinaemia secondary to haematological malignancies in Australia and New Zealand: a clinician survey.

Wong J, Wood EM, Crispin P, Weinkove R, McQuilten ZK; Australasian Leukaemia and Lymphoma Group (ALLG) Supportive Care Group.

Intern Med J. 2019 Mar;49(3):358-363. doi: 10.1111/imj.14082.

PMID:
30129248
11.

A phase I vaccination study with dendritic cells loaded with NY-ESO-1 and α-galactosylceramide: induction of polyfunctional T cells in high-risk melanoma patients.

Gasser O, Sharples KJ, Barrow C, Williams GM, Bauer E, Wood CE, Mester B, Dzhelali M, Caygill G, Jones J, Hayman CM, Hinder VA, Macapagal J, McCusker M, Weinkove R, Painter GF, Brimble MA, Findlay MP, Dunbar PR, Hermans IF.

Cancer Immunol Immunother. 2018 Feb;67(2):285-298. doi: 10.1007/s00262-017-2085-9. Epub 2017 Nov 1.

PMID:
29094183
12.

Glycolipid-peptide conjugate vaccines enhance CD8+ T cell responses against human viral proteins.

Speir M, Authier-Hall A, Brooks CR, Farrand KJ, Compton BJ, Anderson RJ, Heiser A, Osmond TL, Tang CW, Berzofsky JA, Terabe M, Painter GF, Hermans IF, Weinkove R.

Sci Rep. 2017 Oct 27;7(1):14273. doi: 10.1038/s41598-017-14690-5.

13.

Temporal changes in neutropenic blood culture isolates and disease associations: a single centre series of 1139 episodes.

Lucas N, Humble M, Sim D, Balm M, Carter J, Weinkove R.

Intern Med J. 2017 Aug;47(8):962-965. doi: 10.1111/imj.13509.

PMID:
28782216
14.

Red cell transfusion thresholds in myelodysplastic syndromes: a clinician survey to inform future clinical trials.

Mo A, McQuilten ZK, Wood EM, Weinkove R.

Intern Med J. 2017 Jun;47(6):695-698. doi: 10.1111/imj.13434.

PMID:
28580745
15.

Venetoclax and obinutuzumab in chronic lymphocytic leukemia.

Fischer K, Al-Sawaf O, Fink AM, Dixon M, Bahlo J, Warburton S, Kipps TJ, Weinkove R, Robinson S, Seiler T, Opat S, Owen C, López J, Humphrey K, Humerickhouse R, Tausch E, Frenzel L, Eichhorst B, Wendtner CM, Stilgenbauer S, Langerak AW, van Dongen JJM, Böttcher S, Ritgen M, Goede V, Mobasher M, Hallek M.

Blood. 2017 May 11;129(19):2702-2705. doi: 10.1182/blood-2017-01-761973. Epub 2017 Mar 21. No abstract available. Erratum in: Blood. 2017 Jul 13;130(2):232.

16.

Engaging Natural Killer T Cells as 'Universal Helpers' for Vaccination.

Speir M, Hermans IF, Weinkove R.

Drugs. 2017 Jan;77(1):1-15. doi: 10.1007/s40265-016-0675-z. Review.

PMID:
28005229
17.

Immunity without innate lymphoid cells.

Weinkove R, Filbey K, Le Gros G.

Nat Immunol. 2016 Oct 19;17(11):1237-1238. doi: 10.1038/ni.3567. No abstract available.

PMID:
27760103
18.

Non-Invasive Detection of Anaemia Using Digital Photographs of the Conjunctiva.

Collings S, Thompson O, Hirst E, Goossens L, George A, Weinkove R.

PLoS One. 2016 Apr 12;11(4):e0153286. doi: 10.1371/journal.pone.0153286. eCollection 2016.

19.

Innate-like T cell profile in myeloma: Severe deficiency of Vγ9Vδ2 T cells in aminobisphosphonate-treated patients.

Walsh M, White G, Romeril K, Buyck H, Stephens M, Brooks C, Weinkove R.

Leuk Lymphoma. 2016;57(4):977-80. doi: 10.3109/10428194.2015.1088653. Epub 2015 Oct 9. No abstract available.

PMID:
26327461
20.

NKT cell-dependent glycolipid-peptide vaccines with potent anti-tumour activity.

Anderson RJ, Compton BJ, Tang CW, Authier-Hall A, Hayman CM, Swinerd GW, Kowalczyk R, Harris P, Brimble MA, Larsen DS, Gasser O, Weinkove R, Hermans IF, Painter GF.

Chem Sci. 2015 Sep 1;6(9):5120-5127. doi: 10.1039/c4sc03599b. Epub 2015 Jun 25.

21.

An adjuvanted whole cell vaccine as post-remission immunotherapy for acute leukemia.

Weinkove R, Ancelet LR, Gibbins JD, Hermans IF.

Oncoimmunology. 2015 Jan 22;4(4):e995568. eCollection 2015 Apr.

22.

Association between early peak temperature and mortality in neutropenic sepsis.

Weinkove R, Bailey M, Bellomo R, Saxena MK, Tam CS, Pilcher DV, Beasley R, Young PJ.

Ann Hematol. 2015 May;94(5):857-64. doi: 10.1007/s00277-014-2273-z. Epub 2014 Dec 18.

PMID:
25516454
23.

Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014.

Fleming S, Yannakou CK, Haeusler GM, Clark J, Grigg A, Heath CH, Bajel A, van Hal SJ, Chen SC, Milliken ST, Morrissey CO, Tam CS, Szer J, Weinkove R, Slavin MA.

Intern Med J. 2014 Dec;44(12b):1283-97. doi: 10.1111/imj.12595. Review.

PMID:
25482741
24.

An autologous leukemia cell vaccine prevents murine acute leukemia relapse after cytarabine treatment.

Gibbins JD, Ancelet LR, Weinkove R, Compton BJ, Painter GF, Petersen TR, Hermans IF.

Blood. 2014 Nov 6;124(19):2953-63. doi: 10.1182/blood-2014-04-568956. Epub 2014 Sep 18.

PMID:
25237205
25.

Efficient depletion of chronic lymphocytic leukemia B cells using serial rounds of immunomagnetic depletion.

Weinkove R, Brooks CR, Carter JM, Hermans IF, Ronchese F.

J Immunol Methods. 2013 Oct 31;396(1-2):152-6. doi: 10.1016/j.jim.2013.07.004. Epub 2013 Jul 31.

PMID:
23911312
26.

Imipenem versus piperacillin/tazobactam for empiric treatment of neutropenic fever in adults.

Roohullah A, Moniwa A, Wood C, Humble M, Balm M, Carter J, Weinkove R.

Intern Med J. 2013 Oct;43(10):1151-4. doi: 10.1111/imj.12226.

PMID:
23800137
27.

Temperature management in haematology patients with febrile neutropenia: a practice survey.

Weinkove R, Clay J, Wood C.

N Z Med J. 2013 Apr 19;126(1373):62-73.

PMID:
23797078
28.

Vaccination with irradiated tumor cells pulsed with an adjuvant that stimulates NKT cells is an effective treatment for glioma.

Hunn MK, Farrand KJ, Broadley KW, Weinkove R, Ferguson P, Miller RJ, Field CS, Petersen T, McConnell MJ, Hermans IF.

Clin Cancer Res. 2012 Dec 1;18(23):6446-59. doi: 10.1158/1078-0432.CCR-12-0704. Epub 2012 Nov 12.

29.

Functional invariant natural killer T-cell and CD1d axis in chronic lymphocytic leukemia: implications for immunotherapy.

Weinkove R, Brooks CR, Carter JM, Hermans IF, Ronchese F.

Haematologica. 2013 Mar;98(3):376-84. doi: 10.3324/haematol.2012.072835. Epub 2012 Oct 12.

30.

Fever and pancytopenia in a patient with Crohn's disease.

Weinkove R, Dickson M, Eliadou E, Stace NH, Goossens L, Ferguson P.

Gut. 2013 Sep;62(9):1327, 1381. doi: 10.1136/gutjnl-2012-303632. Epub 2012 Oct 6. No abstract available.

PMID:
23042706
31.

Species-specific activity of glycolipid ligands for invariant NKT cells.

Dangerfield EM, Cheng JM, Knight DA, Weinkove R, Dunbar PR, Hermans IF, Timmer MS, Stocker BL.

Chembiochem. 2012 Jun 18;13(9):1349-56. doi: 10.1002/cbic.201200095. Epub 2012 May 25.

PMID:
22639457
32.

Invariant natural killer T cells and asthma: immunologic reality or methodologic artifact?

Brooks CR, Weinkove R, Hermans IF, van Dalen CJ, Douwes J.

J Allergy Clin Immunol. 2010 Oct;126(4):882-5. doi: 10.1016/j.jaci.2010.06.041. Epub 2010 Aug 16. No abstract available.

PMID:
20719374
33.

Fibrinogen concentrate for acquired hypofibrinogenaemic states.

Weinkove R, Rangarajan S.

Transfus Med. 2008 Jun;18(3):151-7. doi: 10.1111/j.1365-3148.2008.00854.x.

PMID:
18598277
34.

Low-dose thalidomide in myelofibrosis.

Weinkove R, Reilly JT, McMullin MF, Curtin NJ, Radia D, Harrison CN.

Haematologica. 2008 Jul;93(7):1100-1. doi: 10.3324/haematol.12416. Epub 2008 May 27. No abstract available.

35.

Zidovudine-induced pure red cell aplasia presenting after 4 years of therapy.

Weinkove R, Rangarajan S, van der Walt J, Kulasegaram R.

AIDS. 2005 Nov 18;19(17):2046-7. No abstract available.

PMID:
16260917
36.

Techniques for predicting a favourable response to renal angioplasty in patients with renovascular disease.

Radermacher J, Weinkove R, Haller H.

Curr Opin Nephrol Hypertens. 2001 Nov;10(6):799-805. Review.

PMID:
11706308

Supplemental Content

Loading ...
Support Center